Clinical Trial Search

Primary: Month 3 Overall Lip Fullness Scale Responder Rate Based on Independent Central Reviewer's Assessment — 34.1; 29.3 Percentage of subjects

Primary: Nasal Tip Projection — 0.601 ratio

Primary: Change in Lip Vessel's Thickness — 0.833; 0.360 µm

Primary: Percentage of Participants With a ≥1-point Increase (Improvement) on the Evaluating Investigator's (EI's) Assessed 5-point Lip Fullness Scale (LFS) — 0; 84.7 percentage…

Primary: Assess Effectiveness of the Treatment Using the Medicis Lip Fullness Scale (MLFS) — 1.8; 1.7; 1.8; 1.8 Change in MLFS score from baseline

Primary: GEIS (Global Esthetic Improvement Scale) Assessed by the Subject at Week 8 After Treatment — 86.2; 86.7 percentage improved subjects

Primary: Investigator Assessment of the Subject's Overall Lip Fullness on the 4-point Lip Fullness Scale — 93.2 percentage of responders

Primary: Change From Baseline in Evaluating Investigator's Assessment of Lip Fullness on a 5-Point Scale — 1.2; 1.1; 1.1; 1.0 Scores on a Scale

Primary: Percentage of Participants With a ≥ 1-point Improvement (Increase) in the Lip Fullness Scale (LFS2) Compared to Baseline Assessment at Day 30 — 93.2 percentage of…

Primary: Percentage of Participants With a ≥ 1 Grade Improvement on the Assessment of Aesthetic Improvement Scale (AAIS) as Assessed by the Central Evaluating Physician at Day…

Primary: Subject Rating of the Natural Look and Feel of the Lips — 52.5; 35.6; 11.9; 0 Percentage of subjects

Primary: Percentage of Subjects With ≥1-Point Improvement on the Investigator Assessed 5-point Lip Fullness Scale 2 (LFS2) — 79.1; 26.1 Percentage of Subjects

Primary: Subject Experience Measured by Patient Satisfaction Questionnaire — 1.94; 1.62; 1.51 Units on a scale

Primary: Percentage of Participants Who Showed ≥ 1-point Jawline Improvement From Baseline on the Allergan Loss of Jawline Definition Scale (ALJDS), as Assessed by the…

Primary: Change in Overall Lip Fullness Grading Scale — 1.52; 1.53 score on a scale

Primary: NLF-SRS Grade of Nasolabial Folds Change — -1.50 score on a scale

Primary: Mean Change From Baseline in Volume Loss Assessment — -0.8 Score on a scale

Primary: Responder Rate in Reduction of Nasolabial Folds — 34; 39; 73 Participants

Primary: Percentage of Participants With Response — 92.6; 28.9 Percentage of Participants

Primary: First Impressions — 46.756; 27.769; 46.391; 34.404 score on a scale

Primary: Blinded Physician Jawline Rating Scale (JRS) Assessment on Scale of 0 to 4 at Baseline Versus 4 Weeks After Last Injection. — 2.214; 2.071; 1.857; 1.857 score on a scale…

Primary: Percentage of Participants Assessed as At Least 1-point Improvement From Baseline on Medicis Lip Fullness Scale (MLFS) — 94.7; 94.7 percentage of participants

Primary: Percentage of Participants With a ≥ 1-point Improvement (Decrease) on the Allergan Chin Retrusion Scale (ACSR) Score — 56.3; 27.5 percentage of participants — p=0.0019

Primary: Number of Participants With Adverse Events — 23; 59; 1; 2 Participants

Primary: Number of Patients With Aesthetic Improvement of the Buttocks Using Investigator GAIS — 7 Participants

Primary: Change in TLFS Score (Teoxane Lip Fullness Scale) Between Baseline and Week 12 After Last Treatment of RHA®3 Versus Control Device, as Assessed by the BLE — 1.0; 0.8…

Primary: Volume Change From Baseline in the Nose Area — -0.005; 2.032 cubic centimeters (cc) — p=<0.0001

Primary: Percentage of Responders — 80; 87.2; 76.7 percentage of subjects

Primary: Change From Baseline in Lip Fullness Grading Scale — .82 score on a scale

Primary: Volumetric Change in Infraorbital Treatment Baseline to Each Post-intervention Timepoint Day 14, Day 30, and Day 90 — -0.026; -0.065; -0.108 cc